|
"kuo yh"的相關文件
顯示項目 6-15 / 116 (共12頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-03-28 |
Prognostic role of claudin-18.2 in intrahepatic cholangiocarcinoma
|
Kuo, YH;Ong, KH;Sun, DP;Tian, YF;Chou, CL;Chan, TC;Hsing, CH;Li, WS;Li, CF;Shiue, YL |
| 國家衛生研究院 |
2024-11 |
DBPR116, a prodrug of BPRMU191, in combination with naltrexone as a safer opioid analgesic than morphine via peripheral administration
|
Lin, SY;Chang, YC;Tien, YW;Kuo, YH;Chang, HF;Ou, LC;Chen, YP;Chang, KH;Hsu, YT;Huang, YC;Yang, CM;Law, PY;Xi, JH;Tao, PL;Loh, HH;Yeh, TK;Zhuang, H;Hsieh, HP;Shih, C;Chen, CT;Yeh, SH;Ueng, SH |
| 國家衛生研究院 |
2024-07-17 |
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia
|
Huang, YH;Lin, SY;Ou, LC;Huang, WC;Chao, PK;Chang, YC;Chang, HF;Lee, PT;Yeh, TK;Kuo, YH;Tien, YW;Xi, JH;Tao, PL;Chen, PY;Chuang, JY;Shih, C;Chen, CT;Tung, CW;Loh, HH;Ueng, SH;Yeh, SH |
| 國家衛生研究院 |
2023-12-15 |
Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma
|
Ong, KH;Lai, HY;Sun, DP;Chen, TJ;Huang, SKH;Tian, YF;Chou, CL;Shiue, YL;Chan, TC;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2023-10-30 |
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma
|
Ong, KH;Hsieh, YY;Lai, HY;Sun, DP;Chen, TJ;Huang, SKH;Tian, YF;Chou, CL;Shiue, YL;Wu, HC;Chan, TC;Tsai, HH;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2023-10-14 |
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma
|
Ong, KH;Hsieh, YY;Lai, HY;Sun, DP;Chen, TJ;Huang, SKH;Tian, YF;Chou, CL;Shiue, YL;Wu, HC;Chan, TC;Tsai, HH;Li, CF;Su, PA;Kuo, YH |
| 國家衛生研究院 |
2023-06-28 |
Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma
|
Liang, PI;Lai, HY;Chan, TC;Li, WM;Hsing, CH;Huang, SK;Hsieh, KL;Tseng, WH;Chen, TJ;Li, WS;Chen, HD;Kuo, YH;Li, CF |
| 國家衛生研究院 |
2023-04-19 |
Prognostic significance of DNA topoisomerase II Alpha (TOP2A) in cholangiocarcinoma
|
Ong, KH;Lai, HY;Sun, DP;Chen, TJ;Huang, SK;Tian, YF;Chou, CL;Shiue, YL;Chan, TC;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2023-03-28 |
Synthesis and structure–activity relationship of salvinal derivatives as potent microtubule inhibitors
|
Chang, CI;Hsieh, CC;Wein, YS;Kuo, CC;Chang, CY;Lung, J;Cherng, JY;Chu, PC;Chang, JY;Kuo, YH |
| 國家衛生研究院 |
2023-03-27 |
Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab
|
Lin, YT;Li, CF;Wu, HC;Jan, YH;Kuo, YH |
顯示項目 6-15 / 116 (共12頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
